Want to see IN:VIVIMEDLAB full AI Analyst Report?
Vivimed Labs Limited (VIVIMEDLAB) Income Statement
Vivimed Labs Limited Income Statement
Last quarter (Q4 2026), Vivimed Labs Limited's total revenue was $120.00M, a decrease of 53.15% from the same quarter last year. In Q4, Vivimed Labs Limited's net income was $-1.47B. See Vivimed Labs Limited’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| $ 699.89M | $ 1.16B | $ 1.49B | $ 1.87B | $ 2.37B | |
| $ -547.76M | $ 77.98M | $ 705.71M | $ -928.65M | $ 838.04M | |
| $ 1.24B | $ 410.70M | $ 853.85M | $ -928.65M | $ 1.09B | |
| Depreciation and Amortization | $ 260.52M | $ 202.24M | $ 199.41M | $ 191.27M | $ 182.80M |
| $ -1.46B | $ -86.77M | $ -246.69M | $ -1.86B | $ -67.91M | |
| $ -1.78B | $ -332.72M | $ -148.14M | $ -1.22B | $ -250.73M | |
| $ 21.49M | $ 14.24M | $ -310.09M | $ -2.09B | $ -387.34M | |
| $ -1.76B | $ -318.48M | $ -458.23M | $ -3.31B | $ -648.33M | |
| $ -1.76B | $ -319.61M | $ -454.46M | $ -3.29B | $ -676.50M | |
| Per Share Metrics | |||||
| Basic EPS | $ -21.15 | $ -3.85 | $ -5.48 | $ -39.62 | $ -8.16 |
| Diluted EPS | $ -21.15 | $ -3.85 | $ -5.48 | $ -39.62 | $ -8.16 |
| Weighted Average Shares Outstanding | 83.44M | 82.99M | 82.91M | 82.91M | 82.91M |
| Weighted Average Shares Outstanding (Diluted) | 83.44M | 82.99M | 82.91M | 82.91M | 82.91M |
Currency in INR
